Western Michigan University School of Medicine
8
2
3
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
12.5%
1 terminated/withdrawn out of 8 trials
66.7%
-19.8% vs industry average
50%
4 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Augmenting the On-Scene Medic (ATOM): A Randomized, Controlled, Multicenter Study to Assess the Effectiveness of Augmented Reality Software on Prehospital Pediatric Medication Administration Accuracy
Role: lead
Harm Reduction for Smokers With Mental Illness
Role: collaborator
The T1D Talks Pilot Study
Role: lead
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
Role: lead
Haloperidol for the Treatment of Nausea and Vomiting in the ED
Role: lead
TOTEM: Trial of TAP Block Effective Medications
Role: lead
IV Haloperidol for the Treatment of Headache in the ED
Role: lead
Evaluation of Naltrexone as a Treatment for Self-injurious Behavior
Role: lead
All 8 trials loaded